Status:
UNKNOWN
Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Lead Sponsor:
Samsung Medical Center
Conditions:
Hemoglobinuria, Paroxysmal
Eligibility:
All Genders
1+ years
Brief Summary
Paroxysmal nocturnal hemoglobinuria (PNH) is a hematopoietic stem cell disorder in which unregulated activation of the complement system leads to significant ischemic morbidities with shortened lifesp...
Detailed Description
To evaluate the clinical characteristics in Korean PNH patients
Eligibility Criteria
Inclusion
- Diagnosis confirmed by Ham's test or Flow cytometry Patients have any Flow cytometry data
Exclusion
- Patients have no Flow cytometry data
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT01224483
Start Date
August 1 2010
End Date
December 1 2010
Last Update
October 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Hematology Oncology, Samsung Medical Center
Seoul, South Korea, 135-710